Similar articles

• [Primary biliary cirrhosis. Primary sclerosing cholangitis].

  Corpechot C, Chazouilleres O. Corpechot C, et al. Gastroenterol Clin Biol. 2003 Mar;27(3 Pt 1):325-32. Gastroenterol Clin Biol. 2003. PMID: 12769103 French. No abstract available.
• Management of autoimmune and cholestatic liver disorders.

  Krok KL, Munoz SJ. Krok KL, et al. Clin Liver Dis. 2009 May;13(2):295-316. doi: 10.1016/j.cld.2009.02.011. Clin Liver Dis. 2009. PMID: 19442920
• [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].

  Stiefelhagen P. Stiefelhagen P. MMW Fortschr Med. 2007 May 24;149(21):49. MMW Fortschr Med. 2007. PMID: 17668736 German. No abstract available.
• [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].

  Thimme R, Opitz OG, Kreisel W. Thimme R, et al. Dtsch Med Wochenschr. 2002 Sep 6;127(36):1823-6. doi: 10.1055/s-2002-33861. Dtsch Med Wochenschr. 2002. PMID: 12215926 Review. German. No abstract available.
• [Recent progress in the diagnosis and therapy of autoimmune hepatitis].

  Zenia M, Toda G. Zenia M, et al. Nihon Naika Gakkai Zasshi. 1999 Sep 10;88(9):1763-7. Nihon Naika Gakkai Zasshi. 1999. PMID: 10581761 Review. Japanese. No abstract available.